These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32134432)

  • 21. [Predictive Biomarkers of Immune-related Adverse Events Induced by Checkpoint Inhibitors in Malignancies].
    Tang H; Guan M; Sun Z; Bai CM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Dec; 42(6):825-830. PubMed ID: 33423733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.
    Li B; Lee MY
    J Biol Chem; 2001 Aug; 276(32):29729-39. PubMed ID: 11375983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohort.
    Khan N; Lipsa A; Arunachal G; Ramadwar M; Sarin R
    Sci Rep; 2017 May; 7(1):2214. PubMed ID: 28533537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies.
    Hernandez C; Arasanz H; Chocarro L; Bocanegra A; Zuazo M; Fernandez-Hinojal G; Blanco E; Vera R; Escors D; Kochan G
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reply to "Immune checkpoint inhibitor-related dermatologic adverse events".
    Stephan C; Khalil J; Abbas O
    J Am Acad Dermatol; 2021 Jun; 84(6):e297-e298. PubMed ID: 33662463
    [No Abstract]   [Full Text] [Related]  

  • 26. Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade.
    Peranzoni E; Ingangi V; Masetto E; Pinton L; Marigo I
    Front Immunol; 2020; 11():1590. PubMed ID: 32793228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice.
    Wang HC; Yeh TJ; Chan LP; Hsu CM; Cho SF
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel mutation in the polymerase delta 1 (POLD1) gene in a lipodystrophic patient affected by mandibular hypoplasia, deafness, progeroid features (MDPL) syndrome.
    Pelosini C; Martinelli S; Ceccarini G; Magno S; Barone I; Basolo A; Fierabracci P; Vitti P; Maffei M; Santini F
    Metabolism; 2014 Nov; 63(11):1385-9. PubMed ID: 25131834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non-small cell lung cancer patients.
    Song P; Yang D; Wang H; Cui X; Si X; Zhang X; Zhang L
    Thorac Cancer; 2020 Jun; 11(6):1647-1654. PubMed ID: 32342665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring checkpoint inhibitors: predictive biomarkers in immunotherapy.
    Zhang M; Yang J; Hua W; Li Z; Xu Z; Qian Q
    Front Med; 2019 Feb; 13(1):32-44. PubMed ID: 30680606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of PD-1/PD-L1 blockade immunotherapy in breast cancer.
    Noguchi E; Shien T; Iwata H
    Jpn J Clin Oncol; 2021 Mar; 51(3):321-332. PubMed ID: 33324990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exome sequencing reveals a de novo POLD1 mutation causing phenotypic variability in mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL).
    Elouej S; Beleza-Meireles A; Caswell R; Colclough K; Ellard S; Desvignes JP; Béroud C; Lévy N; Mohammed S; De Sandre-Giovannoli A
    Metabolism; 2017 Jun; 71():213-225. PubMed ID: 28521875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcomas: Immune biomarker expression and checkpoint inhibitor trials.
    Zhu MMT; Shenasa E; Nielsen TO
    Cancer Treat Rev; 2020 Dec; 91():102115. PubMed ID: 33130422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer.
    Yotsukura M; Nakagawa K; Suzuki K; Takamochi K; Ito H; Okami J; Aokage K; Shiono S; Yoshioka H; Aoki T; Tsutani Y; Okada M; Watanabe SI;
    Jpn J Clin Oncol; 2021 Jan; 51(1):28-36. PubMed ID: 33147608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer.
    Picard E; Verschoor CP; Ma GW; Pawelec G
    Front Immunol; 2020; 11():369. PubMed ID: 32210966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review.
    Kim TJ; Koo KC
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Immune checkpoint inhibitors benefit from routinely measurable peripheral blood parameters.
    Voutsadakis IA
    Chin Clin Oncol; 2020 Apr; 9(2):19. PubMed ID: 32279524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?
    Denis M; Duruisseaux M; Brevet M; Dumontet C
    Front Immunol; 2020; 11():492. PubMed ID: 32265935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular imaging biomarkers for immune checkpoint inhibitor therapy.
    van de Donk PP; Kist de Ruijter L; Lub-de Hooge MN; Brouwers AH; van der Wekken AJ; Oosting SF; Fehrmann RS; de Groot DJA; de Vries EG
    Theranostics; 2020; 10(4):1708-1718. PubMed ID: 32042331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis.
    Venkatesan RN; Treuting PM; Fuller ED; Goldsby RE; Norwood TH; Gooley TA; Ladiges WC; Preston BD; Loeb LA
    Mol Cell Biol; 2007 Nov; 27(21):7669-82. PubMed ID: 17785453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.